156 related articles for article (PubMed ID: 28749974)
1. Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.
Bsteh G; Ehling R; Walchhofer LM; Hegen H; Auer M; Wurth S; Di Pauli F; Wagner M; Reindl M; Deisenhammer F; Berger T
PLoS One; 2017; 12(7):e0181458. PubMed ID: 28749974
[TBL] [Abstract][Full Text] [Related]
2. Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Ehling R; Bsteh G; Di Pauli F; Hegen H; Auer M; Obermair K; Wagner M; Deisenhammer F; Reindl M; Berger T
Mult Scler Relat Disord; 2016 Sep; 9():150-4. PubMed ID: 27645364
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of prognostic biomarkers in optic neuritis.
Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
[TBL] [Abstract][Full Text] [Related]
5. Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
J Neurol; 2010 Jul; 257(7):1188-91. PubMed ID: 20157721
[TBL] [Abstract][Full Text] [Related]
6. Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study.
Cree BAC; Bowen JD; Hartung HP; Vermersch P; Hughes B; Damian D; Hyvert Y; Dangond F; Galazka A; Grosso M; Jones DL; Leist TP
Mult Scler Relat Disord; 2021 Apr; 49():102695. PubMed ID: 33578191
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
Siritho S; Freedman MS
J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
[TBL] [Abstract][Full Text] [Related]
8. Clinical and diagnostic features of patients with familial multiple sclerosis.
Andrijauskis D; Balnyte R; Keturkaite I; Vaitkus A
Med Hypotheses; 2019 Oct; 131():109310. PubMed ID: 31443766
[TBL] [Abstract][Full Text] [Related]
9. Effect of comorbidities on the course of multiple sclerosis.
Puz P; Lasek-Bal A; Steposz A; Bartoszek K; Radecka P
Clin Neurol Neurosurg; 2018 Apr; 167():76-81. PubMed ID: 29459257
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
Mesaroc S; Drulović J; Lević Z; Perić V
Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
[TBL] [Abstract][Full Text] [Related]
11. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
[TBL] [Abstract][Full Text] [Related]
12. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
Mandrioli J; Sola P; Bedin R; Gambini M; Merelli E
J Neurol; 2008 Jul; 255(7):1023-31. PubMed ID: 18535872
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Treatment of Multiple Sclerosis: A Review.
McGinley MP; Goldschmidt CH; Rae-Grant AD
JAMA; 2021 Feb; 325(8):765-779. PubMed ID: 33620411
[TBL] [Abstract][Full Text] [Related]
14. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
[TBL] [Abstract][Full Text] [Related]
15. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.
Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH
Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696
[TBL] [Abstract][Full Text] [Related]
16. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and neurophysiologic findings in patients with multiple sclerosis without oligoclonal IgG in cerebrospinal fluid].
Mesaros S; Drulović J; Lević Z
Srp Arh Celok Lek; 2003; 131(3-4):122-6. PubMed ID: 14608874
[TBL] [Abstract][Full Text] [Related]
18. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis.
Sellner J; Lüthi N; Bühler R; Gebhardt A; Findling O; Greeve I; Mattle HP
Eur J Neurol; 2008 Apr; 15(4):398-405. PubMed ID: 18312402
[TBL] [Abstract][Full Text] [Related]
19. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
[TBL] [Abstract][Full Text] [Related]
20. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
